Tet2 blockade by either Tet2 knockdown or Tet enzyme inhibitor (cell-permeable 2-hydroxyglutarate (2-HG)) significantly decreased VC-induced Cgas expression in liver cancer cells (Fig. 7f, g). The gene discussed is CGAS; the disease is liver cancer.